BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11557186)

  • 1. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients.
    Bhorade SM; Sandesara C; Garrity ER; Vigneswaran WT; Norwick L; Alkan S; Husain AN; McCabe MA; Yeldandi V
    J Heart Lung Transplant; 2001 Sep; 20(9):928-34. PubMed ID: 11557186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.
    Wiita AP; Roubinian N; Khan Y; Chin-Hong PV; Singer JP; Golden JA; Miller S
    Transpl Infect Dis; 2012 Jun; 14(3):248-58. PubMed ID: 22385394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation.
    Hebart H; Gamer D; Loeffler J; Mueller C; Sinzger C; Jahn G; Bader P; Klingebiel T; Kanz L; Einsele H
    J Clin Microbiol; 1998 May; 36(5):1333-7. PubMed ID: 9574700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients.
    Bhorade SM; Lurain NS; Jordan A; Leischner J; Villanueva J; Durazo R; Creech S; Vigneswaran WT; Garrity ER
    J Heart Lung Transplant; 2002 Dec; 21(12):1274-82. PubMed ID: 12490272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients.
    Imbert-Marcille BM; Cantarovich D; Ferre-Aubineau V; Richet B; Soulillou JP; Billaudel S
    Transplantation; 1997 May; 63(10):1476-81. PubMed ID: 9175813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages.
    Keightley MC; Rinaldo C; Bullotta A; Dauber J; St George K
    J Clin Virol; 2006 Dec; 37(4):258-64. PubMed ID: 16978918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
    Smith IL; Taskintuna I; Rahhal FM; Powell HC; Ai E; Mueller AJ; Spector SA; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):178-85. PubMed ID: 9488269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
    Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
    Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry.
    Chemaly RF; Yen-Lieberman B; Castilla EA; Reilly A; Arrigain S; Farver C; Avery RK; Gordon SM; Procop GW
    J Clin Microbiol; 2004 May; 42(5):2168-72. PubMed ID: 15131185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid.
    Goto H; Yuasa K; Sakamaki H; Nakata K; Komuro I; Iguchi M; Okamura T; Ieki R; Tanikawa S; Akiyama H; Onozawa Y; Mochida Y
    Bone Marrow Transplant; 1996 May; 17(5):855-60. PubMed ID: 8733709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients.
    Chemaly RF; Yen-Lieberman B; Chapman J; Reilly A; Bekele BN; Gordon SM; Procop GW; Shrestha N; Isada CM; Decamp M; Avery RK
    Am J Transplant; 2005 Mar; 5(3):544-8. PubMed ID: 15707409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
    Platzbecker U; Bandt D; Thiede C; Helwig A; Freiberg-Richter J; Schuler U; Plettig R; Geissler G; Rethwilm A; Ehninger G; Bornhäuser M
    Transplantation; 2001 Apr; 71(7):880-5. PubMed ID: 11349720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
    Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
    Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes.
    Rollag H; Sagedal S; Holter E; Degré M; Ariansen S; Nordal KP
    Eur J Clin Microbiol Infect Dis; 1998 Feb; 17(2):124-7. PubMed ID: 9629980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods.
    Macartney M; Gane EJ; Portmann B; Williams R
    Transplantation; 1997 Jun; 63(12):1803-7. PubMed ID: 9210508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart--lung allograft recipients.
    Tikkanen J; Lemström K; Halme M; Pakkala S; Taskinen E; Koskinen P
    Clin Transplant; 2001 Apr; 15(2):77-88. PubMed ID: 11264632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.
    Schlischewsky E; Fuehner T; Warnecke G; Welte T; Haverich A; Ganzenmueller T; Heim A; Gottlieb J
    Transpl Infect Dis; 2013 Feb; 15(1):60-9. PubMed ID: 23025532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.